BIO-TECHNE Corp Quarterly Retained Earnings (Accumulated Deficit) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
BIO-TECHNE Corp quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q2 2010 to Q3 2024.
  • BIO-TECHNE Corp Retained Earnings (Accumulated Deficit) for the quarter ending September 30, 2024 was $1.34B, a 1.03% increase year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.34B +$13.6M +1.03% Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $1.33B +$15.8M +1.21% Jun 30, 2024 10-Q 2024-11-05
Q1 2024 $1.3B +$51.1M +4.1% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $1.26B +$61.4M +5.12% Dec 31, 2023 10-Q 2024-02-07
Q3 2023 $1.33B +$165M +14.2% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $1.31B +$187M +16.6% Jun 30, 2023 10-K 2024-08-22
Q1 2023 $1.25B +$114M +10% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $1.2B +$54.3M +4.74% Dec 31, 2022 10-Q 2023-02-07
Q3 2022 $1.16B +$43.2M +3.86% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $1.12B +$37.5M +3.45% Jun 30, 2022 10-K 2023-08-23
Q1 2022 $1.13B +$44M +4.04% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $1.15B +$40.9M +3.7% Dec 31, 2021 10-Q 2022-02-07
Q3 2021 $1.12B +$46M +4.28% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $1.09B +$28M +2.65% Jun 30, 2021 10-K 2022-08-24
Q1 2021 $1.09B +$76.1M +7.51% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $1.1B +$66M +6.35% Dec 31, 2020 10-Q 2021-02-08
Q3 2020 $1.07B +$142M +15.2% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $1.06B +$126M +13.5% Jun 30, 2020 10-K 2021-08-25
Q1 2020 $1.01B +$84.9M +9.16% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $1.04B +$144M +16% Dec 31, 2019 10-Q 2020-02-06
Q3 2019 $931M +$26.2M +2.9% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $932M +$55M +6.27% Jun 30, 2019 10-K 2020-08-26
Q1 2019 $928M +$80.5M +9.5% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $895M +$55.6M +6.63% Dec 31, 2018 10-Q 2019-02-07
Q3 2018 $905M +$103M +12.8% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $877M +$77.9M +9.75% Jun 30, 2018 10-K/A 2019-11-06
Q1 2018 $847M +$68.5M +8.79% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $840M +$70.6M +9.18% Dec 31, 2017 10-Q 2018-02-08
Q3 2017 $802M +$27.7M +3.58% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $799M +$28.5M +3.7% Jun 30, 2017 10-K 2018-08-27
Q1 2017 $779M +$21.9M +2.9% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $769M +$30.5M +4.13% Dec 31, 2016 10-Q 2017-02-09
Q3 2016 $775M +$50.1M +6.92% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $771M +$56.7M +7.94% Jun 30, 2016 10-K 2017-09-07
Q1 2016 $757M +$57.5M +8.22% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $739M +$51.5M +7.49% Dec 31, 2015 10-Q 2016-02-09
Q3 2015 $725M +$58.9M +8.84% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $714M +$60.6M +9.27% Jun 30, 2015 10-K 2016-08-29
Q1 2015 $699M +$61.5M +9.65% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 $687M +$69.3M +11.2% Dec 31, 2014 10-Q 2015-02-09
Q3 2014 $666M +$61.6M +10.2% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 $653M +$65.6M +11.2% Jun 30, 2014 10-K 2015-08-31
Q1 2014 $638M +$65.7M +11.5% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 $618M +$67.6M +12.3% Dec 31, 2013 10-Q 2014-02-04
Q3 2013 $604M +$68.3M +12.7% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $588M +$67.3M +12.9% Jun 30, 2013 10-K 2014-08-29
Q1 2013 $572M +$66.4M +13.1% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 $550M +$62.6M +12.8% Dec 31, 2012 10-Q 2013-02-11
Q3 2012 $536M +$56.3M +11.7% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $520M +$47.7M +10.1% Jun 30, 2012 10-K 2013-08-29
Q1 2012 $506M +$51.4M +11.3% Mar 31, 2012 10-Q 2012-05-10
Q4 2011 $488M +$54.1M +12.5% Dec 31, 2011 10-Q 2012-02-07
Q3 2011 $480M +$62.7M +15% Sep 30, 2011 10-Q 2011-11-09
Q2 2011 $473M +$72.6M +18.1% Jun 30, 2011 10-K 2012-08-29
Q1 2011 $454M Mar 31, 2011 10-Q 2011-05-10
Q4 2010 $433M Dec 31, 2010 10-Q 2011-02-09
Q3 2010 $417M Sep 30, 2010 10-Q 2010-11-09
Q2 2010 $400M Jun 30, 2010 10-K 2011-08-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.